Tag Archives: Illumina

Barclays Remains a Buy on Illumina (ILMN)

In a report released today, Jack Meehan from Barclays maintained a Buy rating on Illumina (ILMN – Research Report), with a price target of $350.00. The company’s shares closed last Monday at $264.14. According to TipRanks.com, Meehan is a 4-star

Illumina (ILMN) Gets a Buy Rating from Credit Suisse

Credit Suisse analyst Lorenzo Biasio maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $340.00. The company’s shares closed last Monday at $293.41. According to TipRanks.com, Biasio is a 4-star analyst with

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Illumina (ILMN – Research Report) and Intuitive Surgical (ISRG – Research Report) with bullish sentiments. Illumina (ILMN) In a report released yesterday,

Illumina (ILMN) Receives a Buy from Piper Jaffray

In a report released today, William Quirk from Piper Jaffray maintained a Buy rating on Illumina (ILMN – Research Report), with a price target of $341.00. The company’s shares closed last Monday at $284.48. According to TipRanks.com, Quirk is a

Illumina (ILMN) Receives a Buy from Credit Suisse

In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Buy rating on Illumina (ILMN – Research Report), with a price target of $340. The company’s shares closed yesterday at $299.38. According to TipRanks.com, Biasio is a 3-star

Analyst Explains Why They Downgraded Their Rating on Illumina (ILMN)

Canaccord Genuity analyst Mark Massaro downgraded Illumina (ILMN – Research Report) to Hold today and set a price target of $300. The company’s shares closed yesterday at $304.41. Massaro said: “We don’t believe an ultra-premium multiple is now justified for